github.com/mims-harvard/ToolUniverse
| Skill | Added | Review |
|---|---|---|
tooluniverse-data-wrangling plugins/tooluniverse/skills/tooluniverse-data-wrangling/SKILL.md Universal data access patterns for downloading and parsing scientific data when ToolUniverse tools don't cover the source, only return metadata, or you need bulk records. Use for VCF/h5ad/BAM/SDF/GCT parsing, multi-step API workflows (search to filter to download to parse), thousands of records at once, or sources with no dedicated tool. Write Python code via Bash for every step. | 74 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-diagnostic-test-evaluation plugin/skills/tooluniverse-diagnostic-test-evaluation/SKILL.md Diagnostic test / biomarker accuracy — sensitivity, specificity, PPV, NPV, likelihood ratios, accuracy from a 2x2 table; ROC curve, AUC, and the optimal cutoff (Youden) for a continuous biomarker; and post-test probability via Bayes. Use when you have test results vs a gold standard (binary 2x2, or a continuous score + true labels) and need to judge how good the test is, pick a threshold, or compute the probability of disease given a result. Emphasizes the prevalence-dependence of PPV/NPV. | 72 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-diagnostic-test-evaluation plugins/tooluniverse/skills/tooluniverse-diagnostic-test-evaluation/SKILL.md Diagnostic test / biomarker accuracy — sensitivity, specificity, PPV, NPV, likelihood ratios, accuracy from a 2x2 table; ROC curve, AUC, and the optimal cutoff (Youden) for a continuous biomarker; and post-test probability via Bayes. Use when you have test results vs a gold standard (binary 2x2, or a continuous score + true labels) and need to judge how good the test is, pick a threshold, or compute the probability of disease given a result. Emphasizes the prevalence-dependence of PPV/NPV. | 75 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-disease-research plugin/skills/tooluniverse-disease-research/SKILL.md Generate comprehensive disease research reports covering genetics (causal genes, GWAS, OMIM), pathways (Reactome, KEGG), drugs (existing therapies, repurposing candidates), clinical trials, epidemiology (prevalence, incidence), and phenotypes (HPO). Use for full disease overviews, comprehensive disease characterization, and orphan/rare-disease profiling. | 66 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-disease-research plugins/tooluniverse/skills/tooluniverse-disease-research/SKILL.md Generate comprehensive disease research reports covering genetics (causal genes, GWAS, OMIM), pathways (Reactome, KEGG), drugs (existing therapies, repurposing candidates), clinical trials, epidemiology (prevalence, incidence), and phenotypes (HPO). Use for full disease overviews, comprehensive disease characterization, and orphan/rare-disease profiling. | 64 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-dose-response plugin/skills/tooluniverse-dose-response/SKILL.md Dose-response / concentration-response curve fitting — IC50, EC50, Hill slope, Emax/Emin efficacy, and relative potency from paired concentration vs response data (enzyme/cell assays, drug screening, agonist/antagonist pharmacology). Fits the 4-parameter logistic (Hill sigmoidal) model. Use when you have concentrations + responses and need a potency value, to compare two compounds' potency, or to judge curve quality. NOT for image-derived dose-response (use tooluniverse-image-analysis) and NOT for survival/regression (use tooluniverse-statistical-modeling). | 74 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-drug-drug-interaction plugin/skills/tooluniverse-drug-drug-interaction/SKILL.md Assess drug-drug interactions — CYP metabolic interactions (substrate/inhibitor/inducer), transporter (P-gp, BCRP, OATP) effects, pharmacodynamic synergy/antagonism, clinical significance scoring, and management recommendations. Use for polypharmacy review, prescribing decision support, and safety analysis when adding or switching drugs. | 71 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-drug-mechanism-research plugin/skills/tooluniverse-drug-mechanism-research/SKILL.md Trace drug mechanism of action — primary target → downstream signaling → pathway perturbation → tissue/organ effect → clinical outcome. Uses DrugBank, ChEMBL, KEGG, Reactome, STRING. Use for understanding how a drug works, identifying off-target effects, mechanism-based combination therapy design, and writing mechanism sections of reports. | 67 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-drug-mechanism-research plugins/tooluniverse/skills/tooluniverse-drug-mechanism-research/SKILL.md Trace drug mechanism of action — primary target → downstream signaling → pathway perturbation → tissue/organ effect → clinical outcome. Uses DrugBank, ChEMBL, KEGG, Reactome, STRING. Use for understanding how a drug works, identifying off-target effects, mechanism-based combination therapy design, and writing mechanism sections of reports. | 67 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-drug-regulatory plugin/skills/tooluniverse-drug-regulatory/SKILL.md Drug regulatory and approval research — FDA substance registry, ATC/EPC classification, EMA decisions, generic-drug status, FDA Orange Book exclusivity, NDA/BLA pathways. Use for jurisdiction-aware approval status (FDA vs EMA), generic vs brand availability, exclusivity expiry tracking, and regulatory pathway selection. Always specifies the market when reporting status. | 71 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-drug-regulatory plugins/tooluniverse/skills/tooluniverse-drug-regulatory/SKILL.md Drug regulatory and approval research — FDA substance registry, ATC/EPC classification, EMA decisions, generic-drug status, FDA Orange Book exclusivity, NDA/BLA pathways. Use for jurisdiction-aware approval status (FDA vs EMA), generic vs brand availability, exclusivity expiry tracking, and regulatory pathway selection. Always specifies the market when reporting status. | 62 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-drug-repurposing plugin/skills/tooluniverse-drug-repurposing/SKILL.md Identify drug repurposing candidates via target-based, compound-based, and disease-based strategies. Combines drug-target-disease network reasoning with mechanism rationale, clinical-trial precedent, and patent/regulatory feasibility. Use for hypothesis-generating repurposing for orphan diseases, finding existing drugs for new indications, and prioritizing candidates by evidence and feasibility. | 66 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-drug-repurposing plugins/tooluniverse/skills/tooluniverse-drug-repurposing/SKILL.md Identify drug repurposing candidates via target-based, compound-based, and disease-based strategies. Combines drug-target-disease network reasoning with mechanism rationale, clinical-trial precedent, and patent/regulatory feasibility. Use for hypothesis-generating repurposing for orphan diseases, finding existing drugs for new indications, and prioritizing candidates by evidence and feasibility. | 68 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-drug-research plugin/skills/tooluniverse-drug-research/SKILL.md Comprehensive drug profiling — mechanism, primary/secondary targets, drug interactions, clinical-trial status, adverse events (FAERS), pharmacogenomics, and approval history. Use for full drug investigation reports, 'tell me about drug X' queries, and assembling drug profiles for clinicians, researchers, or regulatory work. | 66 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-drug-research plugins/tooluniverse/skills/tooluniverse-drug-research/SKILL.md Comprehensive drug profiling — mechanism, primary/secondary targets, drug interactions, clinical-trial status, adverse events (FAERS), pharmacogenomics, and approval history. Use for full drug investigation reports, 'tell me about drug X' queries, and assembling drug profiles for clinicians, researchers, or regulatory work. | 64 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-drug-synergy plugin/skills/tooluniverse-drug-synergy/SKILL.md Drug-combination synergy analysis — quantify whether two drugs together are synergistic, additive, or antagonistic using the standard reference models (Bliss independence, HSA / highest single agent, Loewe additivity, ZIP, and the Chou-Talalay Combination Index). Use when you have measured single-drug and combination effects (inhibition/viability) and need a synergy score. Explains which model to use, what data each one needs, and how to read the score. NOT for looking up pre-computed synergy in a database (use the SYNERGxDB tool / cell-line-profiling skill). | 77 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-drug-synergy plugins/tooluniverse/skills/tooluniverse-drug-synergy/SKILL.md Drug-combination synergy analysis — quantify whether two drugs together are synergistic, additive, or antagonistic using the standard reference models (Bliss independence, HSA / highest single agent, Loewe additivity, ZIP, and the Chou-Talalay Combination Index). Use when you have measured single-drug and combination effects (inhibition/viability) and need a synergy score. Explains which model to use, what data each one needs, and how to read the score. NOT for looking up pre-computed synergy in a database (use the SYNERGxDB tool / cell-line-profiling skill). | 72 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-drug-target-validation plugin/skills/tooluniverse-drug-target-validation/SKILL.md Quantitative drug-target validation pipeline. Scores druggability, selectivity, safety profile, ADMET feasibility, and structural tractability with a composite Target Validation Score (0-100) and GO/NO-GO recommendation. Use for go/no-go decisions on a target before commit-to-medchem, target prioritization across a list, and target-deselection rationale. | 70 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-ecology-biodiversity plugin/skills/tooluniverse-ecology-biodiversity/SKILL.md Ecology, biodiversity, and conservation biology research — species identification (GBIF, NCBI Taxonomy), invasive species impact, ecosystem dynamics, conservation status (IUCN), niche ecology. Use for biodiversity questions, species comparison, invasion biology, conservation prioritization, and ecology-related literature search. | 68 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-ecology-biodiversity plugins/tooluniverse/skills/tooluniverse-ecology-biodiversity/SKILL.md Ecology, biodiversity, and conservation biology research — species identification (GBIF, NCBI Taxonomy), invasive species impact, ecosystem dynamics, conservation status (IUCN), niche ecology. Use for biodiversity questions, species comparison, invasion biology, conservation prioritization, and ecology-related literature search. | 68 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a |